Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.

Saved in:
Bibliographic Details
Title: Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Authors: Packer, M.1,2 milton.packer@baylorhealth.edu, Anker, S. D.3, Butler, J.2, Filippatos, G.4, Pocock, S. J.5, Carson, P.6, Januzzi, J.7, Verma, S.5, Tsutsui, H.8, Brueckmann, M.9,10, Jamal, W.9, Kimura, K.11, Schnee, J.12, Zeller, C.13, Cotton, D.12, Bocchi, E.14, Bohm, M.15, Choi, D.-J.16, Chopra, V.17, Chuquiure, E.18
Source: New England Journal of Medicine. 10/8/2020, Vol. 383 Issue 15, p1413-1424. 12p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa2022190